Home / News / CMS, China talks about the new regulations on PRC...

CMS, China talks about the new regulations on PRC Drug Administration Law and PRC Vaccines Administration Law

25 Sep 19

On September 17, 2019, the French Healthcare Alliance (FHA) Steering Committee held the 6th plenary meeting in Shanghai. Nicolas Zhu, Partner and Head of Lifesciences and Healthcare Sector Group of CMS, China has been invited to give an introduction on new regulations developments in 2019 and 2020 regarding PRC Drug Administration Law and PRC Vaccines Administrative Law in the panel discussion at the meeting. Nicolas outlined the newly revised content of the PRC Drug Administration Law and PRC Vaccines Administration Law, two invoicing issues and shared his opinions on this issue with all the attendees. French pharmaceutical companies attended the event in the presence of General Consul of the General Consulate of France in Shanghai Mr. Benoît GUIDEE.